Roszdravnador noticed a rise in prices on not the vital drugs

Show original
The deputy administrator Federal Service for Supervision in the Sphere of Health Care Dmitry Parkhomenko declared that department noted a rise in prices for medicines, not entering the list vital and the major. Dmitry Parkhomenko during meeting of Advisory council of Committee State Duma of Federal Assembly of the Russian Federation on health protection reported that the prices raise by those drugs, "which for today are not regulated". The deputy administrator Federal Service for Supervision in the Sphere of Health Care also declared that data on increase in the prices of the Russian preparations Federal Service for Supervision in the Sphere of Health Care does not possess. Read also: "Deficiency levotiroksina became a symbol of pharmaceutical crisis: are called...